{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:15:50Z","timestamp":1794071750522,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012612","name":"LSU Health Shreveport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA226285"],"award-info":[{"award-number":["R01 CA226285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015194","name":"Feist-Weiller Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019289","name":"Office of Research-Wichita, School of Medicine, University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neo.2026.101307","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:47:00Z","timestamp":1776469620000},"page":"101307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer"],"prefix":"10.1016","volume":"77","author":[{"given":"Jeyaluxmy","family":"Sivalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleigh","family":"Ballagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6096-014X","authenticated-orcid":false,"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar E","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101307_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.neo.2026.101307_bib0002","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMp048178","article-title":"M.echanisms of androgen-refractory prostate cancer","volume":"351","author":"Debes","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101307_bib0003","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2026.101307_bib0004","article-title":"Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: a population-based study","volume":"100","author":"Zhu","year":"2021","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.neo.2026.101307_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"M.YC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101307_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2026.101307_bib0007","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101307_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2026.101307_bib0009","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2016.03.001","article-title":"N-Myc drives neuroendocrine prostate cancer initiated from Human prostate epithelial cells","volume":"29","author":"Lee","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2026.101307_bib0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","article-title":"N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer","volume":"30","author":"Dardenne","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2026.101307_bib0011","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ng.3315","article-title":"Spatial genomic heterogeneity within localized, multifocal prostate cancer","volume":"47","author":"Boutros","year":"2015","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neo.2026.101307_bib0012","article-title":"The role of L-MYC in prostate cancer","volume":"85","author":"Sivalingam","year":"2025","journal-title":"AACR"},{"key":"10.1016\/j.neo.2026.101307_bib0013","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101307_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-020-01003-9","article-title":"Clinical and biological features of neuroendocrine prostate cancer","volume":"23","author":"Yamada","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.neo.2026.101307_bib0015","first-page":"78","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science (1979)"},{"key":"10.1016\/j.neo.2026.101307_bib0016","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41467-022-29963-5","article-title":"ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer","volume":"13","author":"Nouruzi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101307_bib0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/path.5781","article-title":"Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer","volume":"255","author":"Asrani","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2026.101307_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1947601910379132","article-title":"MYC and prostate cancer","volume":"1","author":"Koh","year":"2010","journal-title":"Genes. Cancer"},{"key":"10.1016\/j.neo.2026.101307_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113221","article-title":"MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer","volume":"42","author":"Crowell","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2026.101307_bib0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neo.2026.101307_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc2578","article-title":"Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer","volume":"7","author":"Patel","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neo.2026.101307_bib0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-pathmechdis-042524-023153","article-title":"M.olecular subtypes of neuroendocrine carcinoma: from chaos to consensus","volume":"21","author":"Wang","year":"2026","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.neo.2026.101307_bib0023","article-title":"Extracellular matrix regulates lineage plasticity in prostate cancer through YAP\/TEAD","author":"Han","year":"2025","journal-title":"bioRxiv."},{"key":"10.1016\/j.neo.2026.101307_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101307_bib0025","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.1009374107","article-title":"Promotion of direct reprogramming by transformation-deficient Myc","volume":"107","author":"Nakagawa","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S.A"},{"key":"10.1016\/j.neo.2026.101307_bib0026","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1101\/gad.279307.116","article-title":"Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer","volume":"30","author":"Kim","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2026.101307_bib0027","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neo.2026.101307_bib0028","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2026.101307_bib0029","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101307_bib0030","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","article-title":"The genomic and epigenomic landscape of double-negative metastatic prostate cancer","volume":"83","author":"Lundberg","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101307_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","article-title":"Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis","volume":"8","author":"Cheng","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.neo.2026.101307_bib0032","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/pros.24448","article-title":"CTPC, a combined transcriptome data set of human prostate cancer cell lines","volume":"83","author":"Cheng","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2026.101307_bib0033","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41467-022-30960-x","article-title":"Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101307_bib0034","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-020-2151-x","article-title":"Landscape of cohesin-mediated chromatin loops in the human genome","volume":"583","author":"Grubert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neo.2026.101307_bib0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.15252\/embj.201490819","article-title":"Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic \u03b2-cell function","volume":"34","author":"Jia","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.neo.2026.101307_bib0036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neo.2026.101307_bib0037","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175217","article-title":"Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer","volume":"134","author":"Ku","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101307_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102953","article-title":"ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung cancer","volume":"24","author":"Pozo","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.neo.2026.101307_bib0039","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1878-0261.12608","article-title":"Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer","volume":"14","author":"Hokari","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.neo.2026.101307_bib0040","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114841","article-title":"Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells","volume":"14","author":"Costanzo","year":"2022","journal-title":"EMBo Mol. Med."},{"key":"10.1016\/j.neo.2026.101307_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113541","article-title":"ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2026.101307_bib0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cellsig.2018.02.014","article-title":"S.onic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer","volume":"46","author":"Chen","year":"2018","journal-title":"Cell Signal."},{"key":"10.1016\/j.neo.2026.101307_bib0043","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cellsig.2013.12.014","article-title":"E.xtra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signal."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:54:39Z","timestamp":1779000879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S1476558626000369"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101307","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101307"}}